ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 937

Evidence of a Common Microglial Signature in Models of ‘Neuropsychiatric Symptoms of Systemic Lupus Erythematosus’

Hadijat M. Makinde1, Elise V. Mike2, Deborah R. Winter3, Chaim Putterman4 and Carla M. Cuda3, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Albert Einstein College of Medicine, Bronx, NY, 3Department of Medicine Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 4Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA, Bronx, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: CNS Lupus and SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Title: 3S109 ACR Abstract: SLE–Animal Models (934–939)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune syndrome affecting multiple organs, including the brain. More than 60% of patients experience neuropsychiatric symptoms of SLE (NPSLE) that often occur early in disease and go undiagnosed. Despite the devastating impact of NPSLE on health-related quality of life, the underlying disease mechanisms are unknown. Microglia are the resident innate immune cells in the brain, and accumulating evidence points to microglia as a source of neurotoxic factors that drive neurodegenerative disease. However, very few studies have examined microglia in the context of NPSLE. Here, microglia isolated from two lupus-prone mouse strains with NPSLE-like disease were evaluated at the transcriptional level to ascertain the existence of a common gene signature.

Methods: Mice with caspase 8 flanked by loxP sites (Casp8fl/fl) were bred to mice expressing Cre under control of the CD11c gene promoter (CreCD11c) to generate CreCD11cCasp8fl/fl mice. The bicongenic B6.Sle1.Sle3 (Sle1,3) strain was derived from the introgression of 2 lupus susceptibility loci from the NZM2410 spontaneous SLE model onto non-autoimmune C57BL/6 (B6) mice. Casp8fl/fl, CreCD11cCasp8fl/fl, B6 and Sle1.3 mice were evaluated for behavioral deficits at 8-10 months of age (n=4/group). Cellular infiltration into the brain was assessed using 10-color flow cytometric analysis. Microglia were sorted for RNA-seq analysis.

Results: We have shown that CD11c-specific deletion of caspase 8, an enzyme in the Fas pathway classically linked to apoptosis initiation and necroptosis suppression, induces an inflammatory disease reminiscent of both human and classic murine models of SLE. CreCD11cCasp8fl/fl mice also exhibit significant impairment in coordination/balance and working memory/learning behaviors similar to patients with SLE. Likewise, the lupus-prone Sle1,3 mouse strain exhibits depression-like behavior and significant impairment in spatial and recognition memory, symptoms detected in SLE patients. In both lupus-prone strains, behavioral deficits correlate with increased leukocyte infiltration including T cells and macrophages. Of the significantly upregulated genes (p<0.05, fold change in expression>1.5) observed in CreCD11cCasp8fl/fl (276) and Sle1,3 (246) microglia compared to their respective controls, 22 genes are shared (p=3.23×10–5, hypergeometric distribution). These shared genes are involved in ‘cell chemotaxis’ (p=7.99×10-4; Vcam1, Slamf8, Cxcl16), ‘scavenger receptor activity’ (p=1.27×10-4; Cxcl16, Lgals3bp), ‘negative regulation of inflammatory response’ (p=1.83×10-4; ApoE, ApoD, Slamf8), ‘negative regulation of lipid metabolic process’ (p=1.38×10-4; ApoE, ApoD, Niacr1) and ‘response to external stimulus’ (p=1.31×10-4; Itgax, Slfn2, ApoE, Axl, Pkd2, Cxcl16, Slamf8).

Conclusion: These data substantiate a common microglial transcriptional signature associated with NPSLE-like disease suggestive of a more regulatory role. In future studies, through examination of other NPSLE models, we will assess the penetrance of this common signature to further interrogate how defective microglial function may incite NPSLE.


Disclosure: H. M. Makinde, None; E. V. Mike, None; D. R. Winter, None; C. Putterman, Exagen Diagnostics, Inc, 2; C. M. Cuda, None.

To cite this abstract in AMA style:

Makinde HM, Mike EV, Winter DR, Putterman C, Cuda CM. Evidence of a Common Microglial Signature in Models of ‘Neuropsychiatric Symptoms of Systemic Lupus Erythematosus’ [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/evidence-of-a-common-microglial-signature-in-models-of-neuropsychiatric-symptoms-of-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evidence-of-a-common-microglial-signature-in-models-of-neuropsychiatric-symptoms-of-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology